IDXX vs. PHG: IDEXX Laboratories vs. Koninklijke Philips Stock Comparison

Company Profile

IDEXX Laboratories (IDXX) and Koninklijke Philips (PHG) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

IDEXX Laboratories (IDXX) trades as ordinary local shares, while Koninklijke Philips (PHG) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

IDEXX Laboratories (IDXX) has an aggressive beta of 1.44, indicating higher sensitivity to broad-market moves, while Koninklijke Philips (PHG) is defensive at 0.65 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

IDEXX Laboratories (IDXX) at 68.93% clears its industry range for ROE, a sharper capital-efficiency signal than Koninklijke Philips (PHG) at 8.61%, which is closer to a typical peer reading.

IDEXX Laboratories (IDXX) at 25.36% retains a top-quartile share of revenue as profit, ahead of Koninklijke Philips (PHG) at 5.39%, which keeps about the industry-typical share.

IDEXX Laboratories (IDXX) at 33.14% operates in the top operating margin quartile, ahead of Koninklijke Philips (PHG) at 3.76%, which runs around its industry’s norm.

Profitability Metrics

Growth

IDEXX Laboratories (IDXX) at 10.42% is around its peer norm for revenue growth, while Koninklijke Philips (PHG) at -1.04% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Only one side can be read here: IDEXX Laboratories (IDXX) reports EPS growth of 22.59%, ranked against its industry; Koninklijke Philips (PHG) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Both IDEXX Laboratories (IDXX) at 1.19 and Koninklijke Philips (PHG) at 1.33 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Both IDEXX Laboratories (IDXX) at 0.52 and Koninklijke Philips (PHG) at 0.70 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Neither IDEXX Laboratories (IDXX) nor Koninklijke Philips (PHG) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Koninklijke Philips (PHG) reports payout ratio above 100% at 211.79%, meaning dividends exceeded current-period earnings; IDEXX Laboratories (IDXX) pays no dividend (payout 0.00%).

Dividend Metrics

Valuation

IDEXX Laboratories (IDXX) at 45.56 is near its industry’s usual P/E ratio, while Koninklijke Philips (PHG) at 63.23 sits in the richer quartile — PHG needs stronger growth or earnings quality to justify the premium.

Koninklijke Philips (PHG) at 1.67 prices around its industry’s typical P/S ratio, while IDEXX Laboratories (IDXX) at 11.42 clears its benchmark range — IDXX looks notably rich on sales.

Koninklijke Philips (PHG) at 2.28 sits near its industry’s typical P/B ratio, while IDEXX Laboratories (IDXX) at 28.50 prices above its benchmark range — IDXX looks rich relative to book.

Valuation Metrics